Male Polycystic Ovary Syndrome Equivalent

    April 2023 in “ Elsevier eBooks
    Ahmed Sayed Mettawi
    Image
    Studysummary This review discusses the potential male equivalent of polycystic ovary syndrome, examining early-onset androgenic alopecia as a marker and current research on risks and diagnostic recommendations, but it reports no new results.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The document discusses the existence of a male equivalent to Polycystic Ovary Syndrome (PCOS), a common endocrine disorder in females. This male equivalent has been hypothesized due to genetic studies and observations of similar abnormalities in first-degree relatives of PCOS patients. Early-onset androgenic alopecia (hair loss) has been proposed as a marker of this syndrome in males. The document reviews the current literature on this male equivalent, the observations in relatives of females with PCOS, the associated risks in males, the sex differences, and the consensus statements on the topic. It aims to provide clinical guidance for screening and diagnosis based on these findings.
    Discuss this study in the Community →

    Research cited in this study

    25 / 25 results